John Scotti is a Research Analyst at Janus Henderson Investors covering the Health Care sector with a focus on the biotechnology industry, a position he has held since joining Janus in 2017. Prior to Janus, Dr. Scotti was director of equity research and senior analyst at Evercore ISI. He started at Evercore in 2014 as an equity research associate.
Dr. Scotti earned his doctoral degree in organic chemistry from the University of Oxford, where he was a Rhodes Scholar. He received his bachelor of science degree in biological chemistry and master of science degree in chemistry from the University of Chicago, graduating with honors and Phi Beta Kappa. Dr. Scotti has 5 years of financial industry experience.